Volume 92 Issue 18 | p. 7 | News of The Week
Issue Date: May 5, 2014 | Web Date: May 2, 2014

Pfizer Pursues AstraZeneca

Acquisitions: Proposed megamerger would create U.K.-based drug giant
Department: Business
Keywords: pharmaceuticals, oncology, acquisitions, taxation

Despite two rejections, Pfizer is trying to persuade AstraZeneca to enter talks about a merger. With the clock ticking and negotiations at a standstill, it’s unclear whether Pfizer will switch from persuasion to a hostile takeover as it continues to press its case.

The U.S. firm first approached U.K.-based AstraZeneca about a combination back in November 2013. At a subsequent meeting in January, Pfizer made a preliminary $100 billion offer of . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society